Non-Current Liabilities
Total Liabilities
Edwards Lifesciences Total Liabilities decreased by 99.3% to $24.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 99.1%, from $2.83B to $24.10M. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows an upward trend with a 4.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ1 2026
How to read this metric
A high level of total liabilities relative to equity indicates a more leveraged capital structure and higher financial risk.
Detailed definition
The aggregate of all current and non-current debts and obligations owed by the company to external parties. It represent...
Peer comparison
Analyzed alongside Total Assets to determine the Debt-to-Asset ratio, which is a standard measure of solvency across all industries.
Metric ID:
total_liabilitiesHistorical Data
19 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.62B | $2.67B | $2.58B | $2.48B | $2.42B | $2.49B | $2.59B | $2.56B | $2.64B | $2.64B | $2.55B | $2.59B | $3.36B | $2.99B | $2.83B | $2.88B | $3.07B | $3.36B | $24.10M |
| QoQ Change | — | +1.8% | -3.4% | -3.6% | -2.5% | +2.7% | +4.2% | -1.2% | +3.4% | +0.0% | -3.6% | +1.8% | +29.5% | -10.9% | -5.4% | +1.8% | +6.4% | +9.5% | -99.3% |
| YoY Change | — | — | — | — | -7.6% | -6.8% | +0.6% | +3.1% | +9.2% | +6.4% | -1.5% | +1.5% | +27.1% | +13.2% | +11.0% | +11.1% | -8.7% | +12.3% | -99.1% |
Range$24.10M – $3.36B
CAGR-64.7%
Avg YoY Growth-1.9%
Median YoY Growth+3.1%
Total Liabilities at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's total liabilities?
- Edwards Lifesciences (EW) reported total liabilities of $24.10M in Q1 2026.
- How has Edwards Lifesciences's total liabilities changed year-over-year?
- Edwards Lifesciences's total liabilities decreased by 99.1% year-over-year, from $2.83B to $24.10M.
- What is the long-term trend for Edwards Lifesciences's total liabilities?
- Over 5 years (2020 to 2025), Edwards Lifesciences's total liabilities has grown at a 4.8% compound annual growth rate (CAGR), from $2.66B to $3.36B.
- What does total liabilities mean?
- The total amount of money the company owes to everyone, both now and in the future.